The Role of Individually Selected Diets in Obese Women with PCOS-A Review

Overview

Journal Nutrients

Date 2022 Nov 11

PMID 36364814

Authors

Izabela Chudzicka-Strugala

Iwona Golebiewska

Beata Banaszewska

Grzegorz Brudecki

Barbara Zwozdziak

Affiliations

Soon will be listed here.

Abstract

Polycystic ovarian syndrome (PCOS) is one of the most common heterogeneous endocrine and metabolic disorders in premenopausal women. It is a complex multifactorial disorder with strong epigenetic and environmental influences, including factors related to eating habits and lifestyle. There is a close relationship between obesity and PCOS. Weight gain and obesity are often clinical symptoms manifested by biochemical markers. Moreover, abdominal obesity in women with PCOS is involved in the development of inflammatory changes. A significant share of balanced therapies correcting the lifestyle of patients is suggested, e.g., with the implementation of appropriate diets to minimize exposure to inflammatory factors and prevent abnormal immune system stimulation. In the case of obese patients with PCOS, planning a diet program and supporting the motivation to change eating habits play an important role to lose weight and lower BMI. Probiotics/synbiotic supplementation may enhance weight loss during the diet program and additionally positively affect metabolic and inflammatory factors by improving the intestinal microbiome.

Citing Articles

Exploring lncRNA expression in follicular fluid exosomes of patients with obesity and polycystic ovary syndrome based on high-throughput sequencing technology.

Xin X, Dong L, Li J, Chen W, Qiu Y, Lian F J Ovarian Res. 2024; 17(1):220.

PMID: 39529075 PMC: 11552169. DOI: 10.1186/s13048-024-01552-8.

Superior metabolic improvement of polycystic ovary syndrome traits after GLP1-based multi-agonist therapy.

Sanchez-Garrido M, Serrano-Lopez V, Ruiz-Pino F, Vazquez M, Rodriguez-Martin A, Torres E Nat Commun. 2024; 15(1):8498.

PMID: 39353946 PMC: 11445520. DOI: 10.1038/s41467-024-52898-y.

Impact of Smoking and Obesity on the Selected Peptide Hormones and Metabolic Parameters in the Blood of Women with Polycystic Ovary Syndrome-Preliminary Study.

Niepsuj J, Piwowar A, Franik G, Bizon A Int J Mol Sci. 2024; 25(16).

PMID: 39201400 PMC: 11354256. DOI: 10.3390/ijms25168713.

Polycystic ovary syndrome and its multidimensional impacts on women's mental health: A narrative review.

Almhmoud H, Alatassi L, Baddoura M, Sandouk J, Alkayali M, Najjar H Medicine (Baltimore). 2024; 103(25):e38647.

PMID: 38905372 PMC: 11191963. DOI: 10.1097/MD.0000000000038647.

BMI and Polycystic Ovary Syndrome: Demographic Trends in Weight and Health.

Mohapatra I, Samantaray S Cureus. 2024; 16(3):e55439.

PMID: 38567220 PMC: 10986768. DOI: 10.7759/cureus.55439.

References

Prathap A, Subhalakshmi T, Varghese P . A Cross-sectional Study on the Proportion of Anxiety and Depression and Determinants of Quality of Life in Polycystic Ovarian Disease. Indian J Psychol Med. 2018; 40(3):257-262. PMC: 5968647. DOI: 10.4103/IJPSYM.IJPSYM_221_17. View

Tojo R, Suarez A, Clemente M, de Los Reyes-Gavilan C, Margolles A, Gueimonde M . Intestinal microbiota in health and disease: role of bifidobacteria in gut homeostasis. World J Gastroenterol. 2014; 20(41):15163-76. PMC: 4223251. DOI: 10.3748/wjg.v20.i41.15163. View

Jensen M, Ryan D, Apovian C, Ard J, Comuzzie A, Donato K . 2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society. Circulation. 2013; 129(25 Suppl 2):S102-38. PMC: 5819889. DOI: 10.1161/01.cir.0000437739.71477.ee. View

Monro J . Redefining the glycemic index for dietary management of postprandial glycemia. J Nutr. 2003; 133(12):4256-8. DOI: 10.1093/jn/133.12.4256. View

Welt C, Gudmundsson J, Arason G, Adams J, Palsdottir H, Gudlaugsdottir G . Characterizing discrete subsets of polycystic ovary syndrome as defined by the Rotterdam criteria: the impact of weight on phenotype and metabolic features. J Clin Endocrinol Metab. 2006; 91(12):4842-8. DOI: 10.1210/jc.2006-1327. View

Rust P, Ekmekcioglu C . Impact of Salt Intake on the Pathogenesis and Treatment of Hypertension. Adv Exp Med Biol. 2016; 956:61-84. DOI: 10.1007/5584_2016_147. View

Zarrati M, Salehi E, Nourijelyani K, Mofid V, Zadeh M, Najafi F . Effects of probiotic yogurt on fat distribution and gene expression of proinflammatory factors in peripheral blood mononuclear cells in overweight and obese people with or without weight-loss diet. J Am Coll Nutr. 2014; 33(6):417-25. DOI: 10.1080/07315724.2013.874937. View

Jenkins D, Wolever T, Taylor R, Barker H, Fielden H, Baldwin J . Glycemic index of foods: a physiological basis for carbohydrate exchange. Am J Clin Nutr. 1981; 34(3):362-6. DOI: 10.1093/ajcn/34.3.362. View

Birdsall M, Farquhar C . Polycystic ovaries in pre and post-menopausal women. Clin Endocrinol (Oxf). 1996; 44(3):269-76. DOI: 10.1046/j.1365-2265.1996.676498.x. View

10.

Rich-Edwards J, Goldman M, Willett W, Hunter D, Stampfer M, Colditz G . Adolescent body mass index and infertility caused by ovulatory disorder. Am J Obstet Gynecol. 1994; 171(1):171-7. DOI: 10.1016/0002-9378(94)90465-0. View

11.

Bueno N, de Melo I, de Oliveira S, Ataide T . Very-low-carbohydrate ketogenic diet v. low-fat diet for long-term weight loss: a meta-analysis of randomised controlled trials. Br J Nutr. 2013; 110(7):1178-87. DOI: 10.1017/S0007114513000548. View

12.

Dhingra D, Michael M, Rajput H, Patil R . Dietary fibre in foods: a review. J Food Sci Technol. 2013; 49(3):255-66. PMC: 3614039. DOI: 10.1007/s13197-011-0365-5. View

13.

Collado M, Isolauri E, Laitinen K, Salminen S . Effect of mother's weight on infant's microbiota acquisition, composition, and activity during early infancy: a prospective follow-up study initiated in early pregnancy. Am J Clin Nutr. 2010; 92(5):1023-30. DOI: 10.3945/ajcn.2010.29877. View

14.

Lee C, Sears C, Maruthur N . Gut microbiome and its role in obesity and insulin resistance. Ann N Y Acad Sci. 2019; 1461(1):37-52. DOI: 10.1111/nyas.14107. View

15.

Vulevic J, Juric A, Tzortzis G, Gibson G . A mixture of trans-galactooligosaccharides reduces markers of metabolic syndrome and modulates the fecal microbiota and immune function of overweight adults. J Nutr. 2013; 143(3):324-31. DOI: 10.3945/jn.112.166132. View

16.

Shang Y, Zhou H, Hu M, Feng H . Effect of Diet on Insulin Resistance in Polycystic Ovary Syndrome. J Clin Endocrinol Metab. 2020; 105(10). DOI: 10.1210/clinem/dgaa425. View

17.

Ferrarese R, Ceresola E, Preti A, Canducci F . Probiotics, prebiotics and synbiotics for weight loss and metabolic syndrome in the microbiome era. Eur Rev Med Pharmacol Sci. 2018; 22(21):7588-7605. DOI: 10.26355/eurrev_201811_16301. View

18.

Green S, Delargy H, Joanes D, Blundell J . A satiety quotient: a formulation to assess the satiating effect of food. Appetite. 1998; 29(3):291-304. DOI: 10.1006/appe.1997.0096. View

19.

Cooney L, Dokras A . Beyond fertility: polycystic ovary syndrome and long-term health. Fertil Steril. 2018; 110(5):794-809. DOI: 10.1016/j.fertnstert.2018.08.021. View

20.

Faghfoori Z, Fazelian S, Shadnoush M, Goodarzi R . Nutritional management in women with polycystic ovary syndrome: A review study. Diabetes Metab Syndr. 2017; 11 Suppl 1:S429-S432. DOI: 10.1016/j.dsx.2017.03.030. View